Enhanced UTI Reporting With With Clinical Context*

*Per CLSI M100 guidelines

counter-02-variant-02-image-1
> 10 million
 UTI office visits annually
counter-02-variant-02-image-2
Up to 30 %
empiric antibiotic prescriptions are inappropriate
                  Source: https://pmc.ncbi.nlm.nih.gov/articles/PMC12224138/                                                                   Source: https://pmc.ncbi.nlm.nih.gov/articles/PMC8225033/

This enhanced reporting is intended to supplement, not replace, routine laboratory reports and standard clinical protocols.
Healthcare providers should continue to follow established diagnostic and treatment guidelines.

Enhanced PCR reporting with AMR analysis and
CLSI M100 intrinsic resistance patterns to advance antibiotic stewardship

Intelligent Reporting Solution

CLSI M100 guidelines tailored to detected pathogens
Provides laboratory interpretation with resistance marker analysis
Seamless integration with existing laboratory workflows

Phone:

CLIA #:

Director:

Patient Name:

MRN:

Accession:

Patient Number:

Birth:

Collection Date:

Provider:

Age:

Received Date:

Home Phone:

Gender:

Specimen Matrix:

Urine

Account:

Pathogen Detected
Pathogen
Example of Pathogen detected

Enterobacter cloacae

Relative Load

HIGH

Resistance Gene Detected
Resistance Gene
Example of Resistance Gene Detected

Fluoroquinolones


Sulfonamides


Trimethoprim


Macrobid comment


Ciprofloxacin, Gemifloxacin, Levofloxacin,
Moxifloxacin, Norfloxacin, Ofloxacin

Sulfadiazine, Sulfamethizole, Sulfamethoxazole,
Sulfasalazine, Sulfisoxazole

Trimethoprim


The organism is carrying antibiotic resistance
markers that correlate with potential Macrobid
(nitrofurantoin) resistance.

Enterobacter cloacae
Antibiotics
Example of Antibiotics

Amoxicillin-clavulanate

Ampicillin

Cefuroxime

Ciprofloxacin

Gentamicin

Levofloxacin

Nitrofurantoin

Tetracycline

Trimethoprim-sulfamethoxazole

Drug Class

Penicillins

Penicillin

Cephalosporin

Fluoroquinolone

Aminoglycosides

Fluoroquinolone

Nitrofuran

Tetracycline

Folate pathway inhibitor combination

Original Reported On:

Accession:

Patient:

Printed:

Lab Result for:

Page 1 of 4

How does this benefit you?

For Reference Labs For Medical Practices
tab-list-image-01 Differentiate your PCR services
tab-list-image-02 Add clinical value without additional equipment
tab-list-image-03 Reduce diagnostic uncertainty in UTI management
Copy of Copy of Untitled Design (2)

Partner with Streamline Scientific to help shape the future of enhanced PCR reporting.

This enhanced reporting is intended to supplement, not replace, routine laboratory reports and standard clinical protocols. Healthcare providers should continue to follow established diagnostic and treatment guidelines.

Want to learn more?
START YOUR LAB
USE OUR LAB
ABOUT
CONTACT

Main Office
2868 Acton Road

Suite 207

Birmingham, AL 35243 1.855.319.4459

See All Locations

© Copyright 2025 | All Rights Reserved | Privacy Policy  | Terms of Use | Do not sell or share my personal information